Effluent-dominated streams. Part 2: Presence and possible effects of pharmaceuticals and personal care products in Wascana Creek, Saskatchewan, Canada

Environmental Toxicology and Chemistry

Volumn 30, Issue 2, 2011, Pages 508-519

  Waiser, Marley J ^a   Humphries, David ^b   Tumber, Vijay ^a   Holm, Jennifer ^a  

^a ENVIRONMENT CANADA   (Canada)

^b Alberta Innovates Technology Futures   (Canada)

Author keywords

Effluent dominated ecosystem; Hazard quotient; Pharmaceuticals; Sewage treatment plants

Indexed keywords

AMERICAN WATERS; ANTI-INFLAMMATORIES; AQUATIC ORGANISMS; AQUATIC SYSTEM; ECOSYSTEM LEVELS; GEMFIBROZILS; HYDROGRAPHS; INSECT REPELLENT; LIPID REGULATORS; MAJOR EVENTS; NANOGRAMS; NAPROXENS; PHARMACEUTICALS; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; SASKATCHEWAN , CANADA; SEWAGE EFFLUENTS; SPRING SNOW; SULFAMETHOXAZOLE; TRICLOSAN; TRIMETHOPRIM;

ANTIBIOTICS; CONCENTRATION (PROCESS); ECOSYSTEMS; EFFLUENT TREATMENT; EFFLUENTS; RIVERS; SEWAGE; SEWAGE TREATMENT; STREAM FLOW; SURVEYS; WATER POLLUTION; WATER QUALITY;

SEWAGE TREATMENT PLANTS;

ACETYLSALICYLIC ACID; AMMONIA; AMOXICILLIN; BENZ[A]ANTHRACENE; BEZAFIBRATE; CAFFEINE; CARBAMAZEPINE; CIPROFLOXACIN; CLOFIBRIC ACID; COCAINE; COTININE; DICLOFENAC; DIETHYLTOLUAMIDE; ERYTHROMYCIN; FENOPROFEN; GEMFIBROZIL; IBUPROFEN; INDOMETACIN; KETOPROFEN; MECLOFENAMIC ACID; NAPHTHALENE; NAPROXEN; NICOTINE; PHENANTHRENE; SALICYLIC ACID; SULFAMETHOXAZOLE; TOLFENAMIC ACID; TRICLOCARBAN; TRICLOSAN; TRIMETHOPRIM;

AMMONIA; ANTIBIOTICS; AQUATIC ORGANISM; CONCENTRATION (COMPOSITION); EFFLUENT; HYDROGRAPH; ION; LIPID; METABOLITE; PHARMACEUTICAL INDUSTRY; POLLUTANT REMOVAL; POLLUTION CONTROL; RISK ASSESSMENT; SEWAGE; SNOWMELT; STREAMFLOW; SURFACE WATER; SURVEY; WATER POLLUTION; WATER TREATMENT;

AQUATIC SPECIES; ARTICLE; CANADA; CONCENTRATION (PARAMETERS); EFFLUENT; ENVIRONMENTAL EXPOSURE; FALLING; HEALTH SURVEY; HYDROGRAPHY; NONHUMAN; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SEWAGE TREATMENT; SEWAGE TREATMENT PLANT; SPRING; STREAM (RIVER); SUMMER; WATER QUALITY; WINTER;

CANADA; COSMETICS; PHARMACEUTICAL PREPARATIONS; RIVERS; SEASONS; SEWAGE; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

CANADA; REGINA; SASKATCHEWAN;

HEXAPODA;

EID: 78651376536     PISSN: 07307268     EISSN: 15528618     Source Type: Journal    
DOI: 10.1002/etc.398     Document Type: Article

References (60)

1. European Medicines Agency. 2006. Guideline on the Environmental Risk Assessment of Medical Products for Human Use. London, UK.
2. Veterinary International Conference on Harmonization. 2004. Environmental Impact Assessment for Veterinary Medicinal Products. Phase II Guidance. Brussels, Belgium.
3. Gunnarsson L, Jauhiainen A, Kristiansson E, Nerman O, Larsson DGJ. 2008. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ Sci Technol 42: 5807-5813.
4. Jones OAH, Voulvoulis N, Lester JN. 2004. Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment. Crit Rev Toxicol 34: 335-350.
5. Daughton CG, Ternes TA. 1999. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ Health Perspect 107: 6: 907-938.
6. Eggen RIL, Behra R, Burkhardt-Holm P, Escher BI, Schweigert N. 2004. Challenges in ecotoxicology. Environ Sci Technol 38: 58A-64A.
7. Fent K, Weston AA, Caminada D. 2006. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76: 122-159.
8. Costanzo SD, Murby J, Bates J. 2005. Ecosystem response to antibiotics entering the aquatic environment. Mar Pollut Bull 51: 218-223.
9. Batt AL, Bruce IB, Aga DS. 2006. Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges. Environ Pollut 142: 295-302.
10. Pomati F, Netting AG, Calamari D, Neilan BA. 2004. Effects of erythromycin, tetracycline and ibuprofen on the growth of Synechocystis sp. and Lemna minor. Aquat Toxicol 67: 387-396.
11. Kidd KA, Blanchfield PJ, Mills KH, Palace VP, Evans RE, Lazorchak JM, Flick RW. 2007. Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci U S A 104: 8897-8901.
12. Brooks BW, Riley TM, Taylor RD. 2006. Water quality of effluent-dominated ecosystems: Ecotoxicological, hydrological, and management considerations. Hydrobiologia 556: 365-379.
13. Waiser MJ, Tumber V, Holm J. 2010. Effluent dominated streams. Part 1: Presence and effects of excess nitrogen and phosphorus in Wascana Creek, Saskatchewan, Canada. Environ Toxicol Chem (this issue).
14. Solomon KR, Baker DB, Richards RP, Dixon KR, Klaine SJ, La Point TW, Kendall RJ, Weisskopf CP, Giddings JM, Giesy JP, Hall LW, Williams WM. 1996. Ecological risk assessment of atrazine in North American surface waters. Environ Toxicol Chem 15: 31-76.
15. Sanderson H, Thomsen M. 2009. Comparative analysis of pharmaceutical versus industrial chemical acute toxicity classification according to the United Nations classification system for chemicals. Assessing the (Q)SAR predictability of pharmaceuticals acute toxicity and their predicted mode-of-action. Toxicol Lett 187: 84-93.
16. Han GH, Hur HG, Kim SD. 2006. Ecotoxicological risk of pharmaceuticals from waste water treatment plants in Korea: Occurrence and toxicity to Daphnia magna. Environ Toxicol Chem 25: 265-271.
17. Quinn B, Gagné F, Blaise C. 2008. The effects of pharmaceuticals on the regeneration of the cnidarian, Hydra attenuata. Sci Total Environ 402: 62-69.
18. Kim Y, Choi K, Jung J, Park S, Kim P-Y, Park J. 2007. Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonilamides, and their potential ecological risks in Korea. Environ Int 33: 370-375.
19. Calow P, ed. 1997. Handbook of Environmental Risk Assessment and Management. Wiley-Blackwell Scientific, London, UK.
20. European Commission. 2003. Technical Guidance Document on Risk Assessment (TGD), 2nd ed, Part II. In support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. EUR 20418 EN/2. European Commission Joint Research Centre, Brussels, Belgium.
21. Ginebreda A, Muñox I, López deAlda M, Brix R, López-Doval J, Barceló D. 2007. Environmental risk assessment of pharmaceuticals in rivers; Relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Environ Int 36: 53-162.
22. Brun GL, Bernier M, Losier R, Doe K, Jackman P, Lee H-B. 2006. Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ Toxicol Chem 25: 2163-2176.
23. Heberer T. 2002. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J Hydrol 266: 175-189.
24. Gagné F, Blaise C, André C. 2006. Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. Ecotoxicol Environ Saf 64: 329-336.
25. Metcalfe CD, Koenig BG, Bennie DT, Servos M, Ternes TA, Hirsch R. 2003. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ Toxicol Chem 22: 2872-2280.
26. Ashton D, Hilton M, Thomas KV. 2004. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 222: 167-184.
27. Kolpin DW, Skopec M, Meyer MT, Furlong ET, Zaugg SD. 2004. Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions. Sci Total Environ 328: 119-130.
28. Christensen AM, Ingerslev F, Baun A. 2006. Ecotoxicity of mixtures of antibiotics used in aquacultures. Environ Toxicol Chem 25: 2208-2215.
29. Solomon KR. 1996. Overview of recent developments in ecotoxicological risk assessment. Risk Anal 16: 627-633.
30. Sanderson H, Johnson DJ, Wilson CJ, Brain RA, Solomon KR. 2003. Probabalistic hazard assessment of environmentally occurring pharmaceutical toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 144: 383-395.
31. Chapman PM, Fairbrother A, Brown D. 1997. A critical evaluation of safety (uncertainty) factors for ecological risk assessment. Environ Toxicol Chem 17: 99-108.
32. Brain RA, Hanson ML, Solomon KR, Brooks BW. 2008. Aquatic plants exposed to pharmaceuticals: Effects and risks. Rev Environ Contam Toxicol 192: 67-115.
33. Brain RA, Ramirez AJ, Fulton BA, Chambliss CK, Brooks BW. 2008. Herbicidal effects of sulfamethoxazole in Lemna gibba: Using p-aminobenzoic acid as a biomarker of effect. Environ Sci Technol 42: 8965-8970.
34. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber L, Buxton HT. 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams 1999-2000: A national reconnaissance. Environ Sci Technol 36: 1202-1211.
35. Zuccato E, Castiglioni S, Fanelli R, Reitano G, Bagnati R, Chiabrando C, Pomati F, Rosetti C, Calamari D. 2006. Pharmaceuticals in the environment in Italy: Causes, occurrence, effects and control. Environ Sci Pollut Res 13: 15-21.
36. Kasprzyk-Holdern B, Dinsdale R, Guwy AJ. 2008. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res 42: 3498-3518.
37. Hirsch R, Ternes TA, Haberer K, Kratz K-L. 1999. Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225: 109-118.
38. Butler MN, Weber WJ Jr. 2005. Accelerated transformation and deactivation of erythromycin in superheated water. 1. Temperature effects, transformation rates, and impacts of dissolved organic matter. Environ Sci Technol 39: 2294-2300.
39. Pomati F, Netting AG, Calamari D, Neilan BA. 2004. Effects of erythromycin, tetracycline and ibuprofen on growth of Synechocystis sp. and Lemna minor. Aquat Toxicol 67: 387-396.
40. Tamtam F, Mercier F, Le Bot B, Eurin J, Dinh QT, Clèment M, Chevreuil M. 2008. Occurrence and fate of antibiotics in the Seine River in various hydrological conditions. Sci Total Environ 393: 84-95.
41. Yang L-H, Ying G-G, Su H-C, Stauber JL, Adams MS, Binet MT. 2008. Growth-inhibiting effects of 12 antibacterial agents and their mixtures on the freshwater microalga Pseudokrchneriella subcapitata. Environ Toxicol Chem 27: 1201-1208.
42. Crane M, Watts C, Boucard T. 2006. Chronic aquatic environmental risks from exposure to human pharmaceuticals. Sci Total Environ 367: 23-41.
43. Carballa M, Omil F, Lema JM, Llompart M, Garcia-Jares C, Rodriguez I, Gomez M, Ternes T. 2004. Behavior of pharmaceutical cosmetics and hormones in sewage treatment plant. Water Res 38: 2918-2926.
44. Brain RA, Johnson DJ, Richards SM, Sanderson H, Sibley PK, Solomon KR. 2004. Effects of 25 pharmaceutical compounds to Lemna gibba using a 7-day static renewal test. Environ Toxicol Chem 23: 371-382.
45. Samsøe-Petersen L, Winter-Nielsen M, Madsen T. 2003. Fate and Effects of Triclosan. Environmental Project 861. Danish Environmental Protection Agency, København, DK.
46. Dussault EB, Balakrishnan VK, Sverko E, Solomon KR, Sibley PK. 2008. Toxicity of human pharmaceuticals and personal care products to benthic invertebrates. Environ Toxicol Chem 27: 425-432.
47. Lawrence JR, Zhu B, Swerhone GDW, Roy J, Wassenaar LI, Topp E, Korber DR. 2009. Comparative microscale analysis of the effects of triclosan and triclocarban on the structure and function of river biofilm communities. Sci Total Environ 407: 3307-3316.
48. Fulton B, Brain R, Usenko S, Back J, King R, Brooks B. 2009. Influence of nitrogen and phosphorus concentrations and ratios on Lemna gibba growth responses to triclosan in laboratory and stream mesocosm experiments. Environ Toxicol Chem 28: 2610-2621.
49. Tan SC, Jackson SHD, Swift SG, Hutta AJ. 1997. Stereospecific analysis of the major metabolites of ibuprofen in urine by sequential achiral-chiral high performance liquid chromatography. J Chromatogr 701: 53-63.
50. Heckmann L-H, Callaghan A, Hooper HL, Connon R, Hutchinson TH, Maund SJ, Sibly RM. 2007. Chronic toxicity of ibuprofen to Daphnia magna: Effects on life history traits and population dynamics. Toxicol Lett 172: 137-145.
51. Zorita S, Märtensson L, Mathiasson L. 2009. Ocurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Sci Total Environ 407: 2760-2770.
52. Lawrence JR, Swerhone GD, Wassenaar LI, Neu T. 2005. Effects of selected pharmaceuticals on riverine biofilm communities. Can J Microbiol 51: 655-669.
53. De Lange HJ, Noordoven W, Murkc AJ, Lürling M, Peeters ETHM. 2006. Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals. Aquat Toxicol 78: 209-216.
54. Quinn B, Gagné F, Blaise C. 2008. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater on the cnidarian Hydra attenuata. Sci Total Environ 389: 306-314.
55. Straub JO, Stewart KM. 2007. Deterministic and probabilistic acute-based environmental risk assessment for naproxen for Western Europe. Environ Toxicol Chem 26: 795-806.
56. Wang S, Holzem R, Gunsch CK. 2008. Effects of pharmaceutically active compounds in a mixed microbial community originating from a municipal wastewater treatment plant. Environ Sci Technol 42: 1091-1099.
57. Andreozzi R, Raffaele M, Nicklas P. 2003. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50: 1319-1330.
58. Carrara C, Ptacek CJ, Robertson WD, Blowes DW, Moncur MC, Sverko E, Backus S. 2008. Fate of pharmaceutical and trace organic compounds in three septic system plumes, Ontario, Canada. Environ Sci Technol 42: 2805-2811.
59. Zurita JL, Repetto G, Jos Á, Salguero M, López-Artíguez M, Caméan AM. 2007. Toxicological effects of the lipid regulator gemfibrozil in four aquatic systems. Aquat Toxicol 81: 106-115.
60. Mimeault C, Woodhouse AJ, Miao X-S, Metcalfe CD, Moon TW, Trudeau VL. 2005. The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus. Aquat Toxicol 73: 44-54.